Home-Based Perimetry for Glaucoma: Where Are We Now?
Summary
Several promising technologies designed for home-based perimetry have been reported.
Abstract
PURPOSE
To systematically summarize the current literature on home-based perimeters for glaucoma.
METHODS
A systematic review was conducted in accordance with the PRISMA-DTA checklist. Studies reporting portable perimeters designed for home use were retrieved from electronic databases and handsearching of reference lists of relevant publications. Studies reporting diagnostic accuracy data were evaluated with the QUADAS-2 tool and using standard automated perimetry as the reference standard. Other aspects of the technology such as detection of disease progression and patient acceptability were also included. Data were reported in a narrative and tabular format.
RESULTS
Of 18 included studies, 10 evaluated tablet-based perimeters, 4 evaluated web-based perimeters, and 4 evaluated head-mounted displays. Most studies used a clinic or laboratory setting. All studies reporting diagnostic accuracy data had high risk of bias in at least one domain. Across studies, sensitivity ranged from 54% in detecting mild to 91% in detecting moderate/severe glaucoma patients from controls, while specificity was between 50% and 100% for any form of glaucoma. The reported acceptability was high but had high risk of bias.
CONCLUSION
Several promising technologies designed for home-based perimetry have been reported. Current studies used a controlled setting in highly selected populations. There is uncertainty on the performance and value of home-based perimetry for glaucoma. Additional efforts are required to elucidate the ability of the home-based perimeters to detect glaucoma and disease progression in real life situations.
More by Qëndresë Daka
View full profile →Top Research in Diagnosis & Screening
Browse all →Efficacy of a Deep Learning System for Detecting Glaucomatous Optic Neuropathy Based on Color Fundus Photographs.
Dry eye disease and oxidative stress.
Central Corneal Thickness in the Ocular Hypertension Treatment Study (OHTS).
Discussion
Comments and discussion will appear here in a future update.